Fri.Jan 10, 2025

article thumbnail

A Decade of FTC v. Actavis: The Reverse Payment Framework is Older, but Are Courts Wiser in Applying It

JD Supra Law

In 2013, the United States Supreme Court significantly changed the landscape of patent settlements in the pharmaceutical industry with its FTC v. Actavis, Inc. decision. In Actavis, the Court held that certain types of so-called reverse paymentspatent litigation settlement payments from brand pharmaceutical manufacturers to generic companies challenging the brands patentmight "sometimes" violate the antitrust laws.

article thumbnail

‘Strike 3’ Filed a Record Number of Piracy Lawsuits in 2024

TorrentFreak

The ease with which IP addresses and BitTorrent downloads can be tracked has created a fertile ground for copyright lawsuits. This inherent transparency has fueled thousands of lawsuits against alleged video pirates, both in the U.S. and around the world. In the United States, Strike 3 Holdings has emerged as a key player in this legal landscape. The company, known for adult entertainment videos published under the ‘Milfy’, Tushy, and Vixen brands, pursues legal action against those

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Overview on the functioning of the trademark system in Europe - Pharma Marks Insights series: Part II

JD Supra Law

As we have seen in the first article of our series, trademarks play an important role in the protection of your pharmaceutical and life science products and can add significant value. But to understand the benefits but also the limits of your trademarks, in particular with the added complexity of market authorization proceedings for products in the field of pharma and life science, it is of paramount importance to get a sense on the functioning of the trademark system in the EU.

article thumbnail

Novartis’ Entresto Patent Claims Revived by CAFC

IP Watchdog

The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential decision reversing a district courts determination that certain claims of a patent for Novartis heart failure drug Entresto were invalid for lack of written description, and affirming a finding that the claims were not shown to be invalid for obviousness, lack of enablement, or indefiniteness.

Patent 52
article thumbnail

Software Composition Analysis: The New Armor for Your Cybersecurity

Speaker: Blackberry, OSS Consultants, & Revenera

Software is complex, which makes threats to the software supply chain more real every day. 64% of organizations have been impacted by a software supply chain attack and 60% of data breaches are due to unpatched software vulnerabilities. In the U.S. alone, cyber losses totaled $10.3 billion in 2022. All of these stats beg the question, “Do you know what’s in your software?

article thumbnail

Is It Really Illegal for Me to Repair My Own Machines?

JD Supra Law

In many cases, the answer is yes, but following a recently-adopted exemption to the Digital Millennium Copyright Act (DMCA), owners of certain retail-level machines are no longer forced to hire OEM-certified technicians to repair the machines they own.

article thumbnail

Navigating Personality Rights – Does Fame Have a Trade-Off?

SpicyIP

Regarding personality rights and introducing a public interest test before granting protection to celebrities, Rebecca Cardoso, in this guest post, advocates for a balanced approach prioritizing protection against genuine harm instead of trivial grievances. Rebecca is a corporate lawyer specializing in financial regulatory practice, with an interest in intellectual property rights.

More Trending

article thumbnail

Applicant Loses Appeal from USPTO Rejection of Cancer Patent Claims

IP Watchdog

The U.S. Court of Appeals for the Federal Circuit (CAFC) today affirmed a Patent Trial and Appeal Board (PTAB) decision that upheld an examiners rejection of certain claims of a patent application for a cancer immunotherapy invention. The opinion was authored by Judge Lourie.

Patent 52
article thumbnail

Interoperability Doesn’t Imply Derivative Work

JD Supra Law

The US Court of Appeals for the Ninth Circuit explained that to be a derivative work, a program interoperative with another must actually incorporate aspects of the underlying work. The Court further ruled that licensees of a copy of a computer program are not owners of the copy and therefore are not entitled to make copies for the purposes permitted by 17 U.S.C. 117(a).

article thumbnail

Columbia Sportswear Tries To Extinguish Patent Challenge

IP Law 360

Columbia Sportswear wants a California federal judge to change his mind about letting a rival pursue a defense in a long-running legal fight over a heat lining design patent, saying that "new facts have emerged" about a challenge to that same patent at the patent office.

Patent 52
article thumbnail

Protecting Your Brand Without Breaking the Bank: 10 Tips for Small Business Owners

JD Supra Law

Every successful business needs two things: a brand and a budget. However developing and protecting your brand without breaking your budget may seem daunting, especially for startups and small businesses. The good news? Its more doable than you might think. Here are ten practical tips to help you develop and protect your trademark on a budget.

article thumbnail

IPO Diversity in Innovation Toolkit

Women and diverse employees have the technical skill and knowledge, yet their contributions are not patented at the same rate as those of their male counterparts.This toolkit can help organizations move the needle on achieving gender parity in innovation.

article thumbnail

Infosys Files Antitrust Counterclaims In Trade Secrets Suit

IP Law 360

Healthcare payments software company Infosys has hit back with antitrust counterclaims against Cognizant TriZetto Software Group's Texas federal court suit accusing Infosys of abusing its system access to develop competing services.

52
article thumbnail

Federal Circuit Review | December 2024

JD Supra Law

Bound to Happen: Inherent Property Leaves No Question of Reasonable Expectation of Success - In Cytiva Bioprocess R&D Ab v. Jsr Corp., Appeal No. 23-2074, the Federal Circuit held that a claim limitation merely reciting an inherent property or result of an otherwise obvious composition or process can be found obvious without finding a reasonable expectation of success.

63
article thumbnail

Landry's Resorted To 'Nasty' Tactics In TM Row, Jury Told

IP Law 360

An attorney for a Texas whiskey-maker told a Houston jury Friday that lawyers for Landry's LLC used "nasty" tactics as he urged the panel to rule that his client hadn't ripped off the name of the restaurant and entertainment conglomerate.

52
article thumbnail

A POSA’s Motivation Is Not Required To Be the Same as the Inventor’s in Evaluating Obviousness

JD Supra Law

In its first precedential opinion of 2025, Honeywell v. 3G Licensing, No. 2023-1354, the Federal Circuit held that a person of ordinary skill in the art (POSA) needs not to have the same motivation as the inventor in an obviousness inquiry, re-emphasizing the Supreme Courts mandate in KSRfor an expansive and flexible approach to obviousness.

article thumbnail

Shoals Again Accuses Voltage Of Patent Infringement At ITC

IP Law 360

Tennessee-based Shoals Technologies Group has launched another legal battle at the U.S. International Trade Commission claiming that North Carolina solar provider Voltage LLC infringed its intellectual property relating to solar power installations.

article thumbnail

USPTO Trademark Fee Increases May Help Reshape Examining Efficiency

JD Supra Law

The U.S. Patent and Trademark Offices (USPTO) biannual fee increase is now in effect. The USPTO anticipates the fee increases and the addition of new fees will significantly streamline the application process in addition to helping support the USPTOs operating budget.

article thumbnail

AstraZeneca Widens Blockbuster Cancer Drug Patent Fight

IP Law 360

AstraZeneca on Thursday hit Zydus, Sandoz, Natco and Cipla with suits in New Jersey federal court accusing them of infringing a patent covering the drug Lynparza, expanding its fight against the generic-drug makers over their efforts to sell or produce the blockbuster cancer treatment.

Patent 52
article thumbnail

Other Barks and Bites for Friday, January 10: CAFC Affirms Copyright Judgment Against U.S. Navy; Cruz to Chair Senate Commerce Committee; EUIPO/EPO Joint Study Shows IP Rights Improve Wages

IP Watchdog

This week in Other Barks and Bites: U.S. District Judge James Selna adds pre-judgment interest, increasing a jury verdict for patent infringement against Western Digital to $553 million; the Copyright Royalty Board provides clarification on the definition of gross proceeds for a rate setting proceeding; Senator Ted Cruz (R-TX) will serve for the first time as the Chairman of the Senate Commerce Committee; and more.

article thumbnail

Masimo, Apple Fight Over Watch IP In Post-Bench Trial Briefs

IP Law 360

Masimo and Apple have submitted dueling briefs to a California federal judge following a trade secret retrial over health sensing technology in Apple's smartwatches, with Masimo maintaining Apple poached its employees to steal its intellectual property and Apple contending Masimo failed for years to "back up their spurious claims" of misappropriation.

article thumbnail

Motivation MIA? Federal Circuit Sends IPR Back to the Drawing Board

JD Supra Law

The US Court of Appeals for the Federal Circuit vacated and remanded a Patent Trial & Appeal Board decision, finding that the Board erred by failing to explain its holding and reasoning regarding a motivation to combine prior art references. Palo Alto Networks, Inc. v. Centripetal Networks, LLC, Case No. 23-1636 (Fed. Cir. Dec. 16, 2024) (Stoll, Dyk, Stark, JJ.).

Art 63
article thumbnail

GSK Hits Back At Moderna Counterclaims In Patent Fight

IP Law 360

GlaxoSmithKline wants a Delaware federal court to quickly reject some of the counterclaims leveled by Moderna in response to patent suits over the company's mRNA vaccines.

Patent 52
article thumbnail

@FTC to AI (and other) Companies: Quietly Changing Your Terms of Service Could Be Unfair or Deceptive

The Trichordist

FTC lays down a warning about AI platforms deceptive trade practices and conflicts from snarfing down user creations in their social media business to feed the AI beast.

article thumbnail

Microsoft Pushes To Thwart 'Scheme' To Bypass AI Security

IP Law 360

A Virginia federal judge has authorized Microsoft Corp. to seize a website that the tech giant alleges has been instrumental to a "sophisticated scheme" by foreign-based cybercriminals to circumvent safety guardrails built into artificial intelligence services in order to create offensive and harmful content, according to court filings made public Friday.

52
article thumbnail

Reviewing 2024's AI Patent And Copyright Developments

JD Supra Law

Artificial intelligence dominated this year's emerging technology updates from the U.S. Patent and Trademark Office and the U.S. Copyright Office. These agencies, among many others, were kept quite busy under the directives set forth in President Joe Biden's Oct. 30, 2023, executive order on the safe, secure, and trustworthy development and use of AI.

article thumbnail

4 Lessons For Contractors From The Bitmanagement Saga

IP Law 360

A software company's damages award of just $150,000 after years of litigation over the U.S. Navy violating a licensing deal offers several lessons for federal software contractors about carefully negotiating contractual terms and making sure they can adequately enforce those terms.

article thumbnail

Challenges of Copyright Law in the Global South: Addressing the Knowledge Divide

Intepat

Introduction Copyright law plays a crucial role in regulating the distribution and protection of creative works, but its impact is not uniform across the world. In the Global South, the challenges posed by copyright law are particularly significant, often hindering access to knowledge and limiting opportunities for development. The high costs of copyrighted educational and research materials, combined with the dominance of large corporate players, have created a divide that leaves many communiti

article thumbnail

What's Next After Fed. Circ. Limits Orange Book Listings?

IP Law 360

Under the Federal Circuit's recent ruling that patents must claim a drug's active ingredient to be included in the U.S. Food and Drug Administration's Orange Book, many patents may be listed improperly, but their fate and the ruling's impact on generic competition are far from settled, attorneys say.

Patent 52
article thumbnail

The End of Fact-Checking at Facebook is Ideologically Consistent

The Illusion of More

The announcement that Meta will stop fact-checking material on its platforms is neither surprising nor, at this point, relevant. Mark Zuckerbergs absurd announcement that the company is getting back to core principles, or whatever b t way he said it, is no more appalling today than that same rhetoric has been for decades. None of this […] The post The End of Fact-Checking at Facebook is Ideologically Consistent appeared first on The Illusion of More.

67
article thumbnail

Fed. Circ. Skeptical Ioengine Can Overcome On-Sale Bar

IP Law 360

A Federal Circuit panel seemed doubtful Friday that none of the hundreds of people who downloaded a firmware upgrade affiliated with an early flash drive used it, which Ioengine LLC would need to prove to beat an on-sale bar invalidation of its patents.

Patent 52
article thumbnail

Transparency Is the Best Medicine: Device Parts Don’t Justify Orange Book Listing

JD Supra Law

The US Court of Appeals for the Federal Circuit affirmed a district courts delisting of patents from the Orange Book because the patent claims did not claim the drug that was approved or the active ingredient of the drug that was approved. Teva Branded Pharmaceutical Products R&D, Inc., et al. v. Amneal Pharmaceuticals of New York, LLC, et al., Case No. 24-1936 (Fed.

article thumbnail

Patent Partner Leaves Kilpatrick Townsend For K&L Gates

IP Law 360

K&L Gates LLP has added to its Orange County, California, office a Kilpatrick Townsend & Stockton LLP partnerwith a practice of working with Chinese companies looking to file patents with the U.S. Patent and Trademark Office.

Patent 52
article thumbnail

Challenges of Pre-Existing Conditions in Ontario Car Accident Claims

Nelligan Law

Reading Time: 2 minutes Navigating an Ontario car accident claim becomes more complex when pre-existing conditions are involved. Insurance companies often scrutinize these cases, trying to attribute injuries to prior health issues instead of the accident. Lets discuss how pre-existing conditions affect the compensation process and strategies to manage these challenges effectively.

Law 52
article thumbnail

Fed. Circ. Revives Novartis Entresto Patent In MDL

IP Law 360

The Federal Circuit on Friday revived a patent covering Entresto, a blockbuster heart failure drug made by Novartis, as part of multidistrict litigation where the company has tried to block generic versions of the product.

Patent 52
article thumbnail

Maximizing Compensation through Insurance Coverage in Ontario Car Accident Claims

Nelligan Law

Reading Time: 2 minutes After a car accident, navigating the insurance claims process can be daunting. Understanding your Ontario car insurance coverage and effectively claiming under each component is crucial for maximizing compensation. Heres how to approach the claims process strategically to ensure you receive the compensation you deserve. Understanding Your Ontario Car Insurance Coverage To maximize your claim, its important to know the types of coverage available in your policy: Liability

article thumbnail

NC Machinery Co. Says Rival Lied To Hide Trade Secrets Theft

IP Law 360

A North Carolina machining tools manufacturer is suing the American arm of its Germany-based rival in state Business Court, claiming the competitor has been hiring away its talent to acquire its trade secrets and then misrepresenting its job descriptions to hide the alleged scheme.